New Zealand's E-cigarette Retail Growth Raises Concerns

Oct.06.2022
New Zealand's E-cigarette Retail Growth Raises Concerns
New Zealand sees a surge in vaping retailers, causing concern for CEO of the Asthma and Respiratory Foundation.

Letitia Harding, CEO of the Asthma and Respiratory Foundation New Zealand, has pointed out that the significant increase in the index of professional e-cigarette retailers in New Zealand over the past 12 months is a cause for concern.


As of February 2022, there are 666 registered professional e-cigarette retailers in New Zealand, and as of today, we now have 956. To put this in perspective, New Zealand has a total of 267 KFC and McDonald's restaurants. We have heard firsthand from the community that they are tired of e-cigarette shops popping up everywhere, with their products displayed in storefront windows," states Harding.


While regulations exist to oversee electronic cigarette stores, the foundation is concerned that these regulations are not being fully implemented and that retailers are taking advantage of the current environment to maximize their profits.


We don't need 934 specialized e-cigarette retailers. This means that e-cigarettes are easily accessible and readily available, which will only fuel the popularity of e-cigarettes among New Zealand teenagers," she said.


The foundation is particularly concerned about the widespread existence of "professional electronic cigarette retailers" that are being built within existing convenience stores. "This is a loophole that many retailers have been utilizing to sell more electronic cigarette products," she explained. "According to current regulations, only professional electronic cigarette retailers are allowed to sell the full range of electronic cigarette flavors.


The foundation believes that fundamentally changing the regulations surrounding tobacco products in smoke-free environments and amending the controlled products legislation is a timely opportunity to address the harm caused by electronic cigarette products. In the proposed legislation, the foundation is calling for stricter controls on e-cigarette retailers and a reduction in the nicotine content of e-cigarette products.


Dr. Stuart Jones, a respiratory advisor and consultant, stated that while this bill has changed the game for how New Zealand addresses the harms caused by tobacco cigarettes, there is still a need to address the widespread use of Electronic Nicotine Delivery Systems (ENDS) among young people.


We have too many young people who have become addicted to nicotine through the use of electronic cigarette products. We can no longer wait a few more years to establish better regulations regarding ENDS products, as the magnitude of this problem will only continue to grow. Reducing the nicotine content in electronic cigarette products needs to be treated as an urgent matter. We need retailers to be kept away from our school environments and we need better regulation of these retailers," he said.


Statement:


This article is a compilation of information from third-party sources and is intended for industry professionals for educational and exchange purposes.


This article does not represent the views of 2FIRSTS and 2FIRSTS is not able to confirm the truthfulness and accuracy of the content. The translation of this article is intended only for industry communication and research.


Due to limitations in translation proficiency, the article may not accurately reflect the original text. Please refer to the original text for accuracy.


2FIRSTS maintains complete alignment with the Chinese government regarding any domestic, Hong Kong, Macau, Taiwan, or international issues and stances.


The copyright of the compiled information belongs to the original media and author. If there is any infringement, please contact us for deletion.



Disclaimer

This article is provided solely for professional research, industry discussion, and informational purposes. Any references to brands, companies, products, technologies, or policies are made for factual reporting and analytical purposes only, and do not constitute endorsement, recommendation, promotion, or advertising by 2Firsts.

Nicotine-containing products, including but not limited to cigarettes, e-cigarettes, heated tobacco products, and nicotine pouches, carry significant health risks. Readers are responsible for complying with all applicable laws and regulations in their respective jurisdictions, including age restrictions and access limitations.

The information contained in this article should not be regarded as investment, legal, medical, regulatory, or commercial advice. While 2Firsts strives to ensure the accuracy and reliability of its content, it does not assume liability for any direct or indirect loss arising from errors, omissions, inaccuracies, or reliance on the information contained herein.

This article is not intended for individuals below the legal age for accessing tobacco or nicotine-related information in their jurisdiction.

 

Copyright Notice

This article is either original content produced by 2Firsts or content reproduced, translated, summarized, or adapted from third-party sources with attribution where applicable. The intellectual property rights of the original content remain with 2Firsts or the respective original rights holders.

No individual or organization may copy, reproduce, distribute, republish, modify, translate, or otherwise use this content without prior authorization. Any unauthorized use may result in legal action.

For copyright-related inquiries, corrections, or removal requests, please contact: info@2firsts.com.

 

AI-Assisted Translation and Editing Notice

Portions of this article may have been translated, edited, or reviewed with the assistance of artificial intelligence tools to improve efficiency and readability. Due to the limitations of AI-assisted translation and editing, discrepancies, omissions, or inaccuracies may exist when compared with the original source.

Where applicable, readers are advised to refer to the original source for the most complete and accurate information. If you identify any errors or believe that any content infringes upon your rights, please contact us at info@2firsts.com, and we will review and address the matter promptly.

From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
From Product Innovation to Integrated Solutions: NEXTECH Expands Its Global Heated Tobacco Solutions
NEXTECH launched its NEXE Pro circumferential-heating tobacco stick globally at InterTabac 2026, as the company expands from product innovation into broader heated tobacco solutions. Amid intensifying competition across global HTP markets, NEXTECH is strengthening its R&D, manufacturing and pre-launch support capabilities to serve different types of business customers.
Industry Insight
Sep.15
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Product | PMI Launches ZYN Melts in UK, Extending ZYN Beyond Nicotine Pouches Into Dissolvable Tablets
Philip Morris International (PMI) has launched ZYN Melts in the UK, introducing a fully dissolvable oral nicotine tablet format alongside the brand's existing nicotine pouches. The range includes Cool Mint and Peppermint, each offered at 1mg and 2mg of nicotine per tablet, creating four SKUs. Each can contains 20 tablets and is priced at £6.50 in the UK. Unlike ZYN nicotine pouches, Melts are placed between the upper lip and gum and dissolve completely during use.
News
Sep.29 by 2Firsts Perspectives
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
PMI Expands Its Second Global and First Asian Business Services Hub in the Philippines, Serving 160 Markets and Scaling Up AI Capabilities
Philip Morris International's PMI Business Solutions Philippines has expanded its global business services hub in Makati and plans to add more than 80 positions. Established in 2021 primarily to provide finance and IT support to about 20 markets, the center now employs 519 professionals delivering roughly 600 services across 160 markets. Its functions now span finance, human resources, IT, commercial operations, data analytics, supply chain and project management. PMI says the hub's next phase will focus on AI-enabled and higher-value work. The company did not disclose the size or investment cost of the expansion.
Sep.24
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia’s Vape Device Labeling Regime Enters Force: Registration Starts in September, Mandatory Coding in December
Russia's digital labeling regime for reusable e-cigarettes and similar personal vaping devices entered its first mandatory phase in September 2026. From September 1, manufacturers, importers and other market participants must register with the national Chestny ZNAK tracking system. From December 1, newly manufactured and imported covered devices will be required to carry digital identification codes and be reported as entering circulation. Russia has also issued new operational guidance for imports, marking the transition from a voluntary pilot to phased mandatory implementation.
Sep.15
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
FDA Unifies Tobacco Registration and Product Listing Form Across Product Categories
The U.S. FDA has consolidated two tobacco establishment registration and product listing forms into a redesigned Form FDA 3741 covering all regulated product categories, including e-cigarettes, heated tobacco products and nicotine pouches. The current requirements remain limited to domestic establishments. Separately, the FDA has proposed extending registration and product listing requirements to foreign manufacturers, signaling greater regulatory attention to manufacturing entities and product-level information across the tobacco and nicotine supply chain.
FDA
Sep.30
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Reynolds Seeks to Join Altria Lawsuit Challenging FDA PMTA Rule and Calculation of 180-Day Deadline
Three R.J. Reynolds companies are seeking to intervene in a lawsuit filed by Altria subsidiaries Helix Innovations and NJOY challenging the FDA's 2021 PMTA final rule. The companies dispute how the agency uses Acceptance and Filing reviews and completeness determinations to establish when the Tobacco Control Act's 180-day decision period begins. Reynolds has also linked prolonged PMTA reviews to competition from unauthorized vaping products. The FDA, meanwhile, has been accelerating reviews and reducing its backlog.
Sep.14